{
  "id": "prt_95dd99136001iSRyqClJyySDB0",
  "messageID": "msg_95dd7de6e0010mpLojyFCvVBV2",
  "sessionID": "ses_6a7af0913ffePKeafEVjU8Zw0Y",
  "type": "text",
  "text": "Perfect! ✅ **D-A-CH Consensus Statement successfully added to VisibleDx resources:**\n\n## **📚 New Reference Added:**\n\n**\"D-A-CH Consensus Statement on Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)\"**\n- 🔗 **URL**: https://pmc.ncbi.nlm.nih.gov/articles/PMC11093804/\n- 📅 **Published**: 2024\n- 🌍 **Region**: Germany, Austria, Switzerland consensus\n\n## **🔄 Updated Locations:**\n\n### **1. Footer Guidelines Section**\n- ✅ Added \"D-A-CH ME/CFS Consensus (2024)\" \n- ✅ Positioned after CDC guidelines (logical hierarchy)\n\n### **2. Navigation Guidelines Menu**\n- ✅ Added to clinical guidelines dropdown\n- ✅ Organized by organization (D-A-CH)\n\n### **3. Translation Files**\n- ✅ **English**: \"D-A-CH ME/CFS Consensus (2024)\"\n- ✅ **Dutch**: \"D-A-CH ME/CVS Consensus (2024)\" \n- ✅ **Danish**: \"D-A-CH ME/CFS Konsensus (2024)\"\n\n## **📋 Current Evidence Base:**\n1. **CDC ME/CFS Guidelines** (US, 2024)\n2. **D-A-CH ME/CFS Consensus** (DACH, 2024) 🆕\n3. **NASEM ME/CFS Report** (US, 2015)\n4. **WHO Long COVID Definition** (Global, 2021)\n5. **ESC POTS Guidelines** (Europe, 2018)\n\nYour VisibleDx application now includes the latest European consensus on ME/CFS diagnosis and treatment, enhancing its evidence base with international perspectives! 🚀\n\nThe D-A-CH consensus is particularly valuable as it represents the most recent collaborative guidelines from Germany, Austria, and Switzerland medical communities.",
  "time": {
    "start": 1758216173416,
    "end": 1758216173416
  }
}